Omalizumab ‘cuts seasonal asthma attacks in youth’ – DailyIndia.com


LiveScience.com

Omalizumab 'cuts seasonal asthma attacks in youth'
DailyIndia.com
London, Mar 17: A clinical trial has found that the drug omalizumab, sold under the brand name Xolair, nearly eliminated seasonal increases in asthma attacks and decreased asthma symptoms among inner-city children and youth.
Drug may relieve kids' asthma in the fallmsnbc.com
Xolair Relieves Kids' Seasonal Asthma Attacks: StudyWebMD
Asthma Drug Cuts Seasonal Flares for Inner-City KidsMedPage Today
U.S. News & World Report –Bloomberg –Medscape
all 41 news articles »

View full post on asthma – Google News

Xolair Relieves Kids’ Seasonal Asthma Attacks: Study – WebMD

Xolair Relieves Kids' Seasonal Asthma Attacks: Study
WebMD
March 16, 2011 — The asthma drug Xolair (omalizumab) improves asthma control, nearly eliminates seasonal flare-ups, and allows reductions in the doses of other asthma control medications in children as young as 6, according to a new
Novartis, Roche's Xolair Helps Stop Asthma Attacks in ChildrenBloomberg

all 2 news articles »

View full post on asthma – Google News

New device can predict asthma attacks – Daily News & Analysis


Daily Mail

New device can predict asthma attacks
Daily News & Analysis
Researchers have developed a new device that can tell if an asthma sufferer is close to having an attack hours in advance. The handheld sensor could give
New device can predict asthma attacksTopNews
Siemens gas-sensor device to predict asthma attacksUberGizmo
Gas-sensor device can predict asthma attacksThe Engineer

all 7 news articles »

View full post on asthma – Google News